Patient journey
Optimising the patient journey
Find out how improved diagnosis could lead to improved prognosis.
Patient journey
Individuals diagnosed with AL amyloidosis have a wide range of experiences. Take a look at this hypothetical journey of a patient, and then see the potential impact improved awareness and cross-disciplinary collaboration could have made.
A patient with AL amyloidosis
2+ YEARS TO IDENTIFY
which impacts both morbidity and mortality[1]
NT-proBNP=N-terminal pro-B-type natriuretic peptide
Improved awareness and collaboration among specialists
ACCURATE DIAGNOSIS
IS MADE MUCH SOONER
Treatment begins sooner[1]
ECG=electrocardiogram.
AL amyloidosis can cause a number of vague symptoms and affect the body in several ways.
AL amyloidosis is defined by a variety of symptoms. Awareness of the key symptoms is essential.
There are various factors to consider when AL amyloidosis is suspected.
Working together for improved prognosis
What are the current treatments and techniques to manage patients with AL amyloidosis? In this short 4-minute video, Dr Vaishali Sanchorawala (haematology/oncology) and Dr Omar Siddiqi (cardiology) discuss the importance of multidisciplinary collaboration in the decision-making process in order to transform AL amyloidosis into a manageable chronic condition.
Download this information on AL amyloidosis
